Aurinia Pharmaceuticals Inc. (NASDAQ:$AUPH) shares
Post# of 22755
What Analysts Say About Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH)
Stock has got outperform rating from no analyst of Thomson Reuters whereas no analyst given hold rating to the stock. Analyst’s mean target price for the firm is $8.90 while analysts mean recommendation is 1.50.
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) announced that its Chief Executive Officer, Charles Rowland, will present a corporate overview of the Company at the 2016 BIO Investor Forum, taking place October 18-19 at the Westin St. Francis in San Francisco.
NASDAQ DIP and RIP
Here is the best word that describes what i do here.
Intuitive;
means having the ability to understand or know something without any direct evidence or reasoning process.
I was born with it, I'm truly blessed!
Alway's searching for winners'